Joby Aviation Diversifies Revenue Amid Stock Price Collapse

Joby Aviation has seen its stock price decline by more than 54% this year, a result of rising operating expenses, dilution, and high cash burn. Investors remain concerned over the timeline for type certification from the Federal Aviation Administration, which is required before the company can transport paying passengers.

To stabilize its financial position, the company is diversifying its revenue streams. Joby has acquired Blade Air Mobility and Strata Critical Medical, and it plans to acquire Resonant Sciences, a defense business. These moves aim to generate immediate income while the company works toward its long-term goals.

Joby plans to begin operations across 11 states in 2026 to gather real-world flight experience. The company targets the launch of commercial passenger services in high-traffic urban areas, including New York City, as early as 2027. Joby expects total revenue between $115 million and $125 million this year, with analysts projecting the revenue base could grow to nearly $500 million by 2028.